From: Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models
Mice group/Marker
CR positive
Positive MMP-9
Ctrl (at end)
50%
71%
(n = 7)
Doxycycline/TUDCA
0%
29%
Doxycycline
40%
(n = 9)
TUDCA
67%